Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension
Purpose
The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is >= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of >= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (>= 180 SBP).
Condition
- Maternal Hypertension
Eligibility
- Eligible Ages
- All ages
- Eligible Genders
- Female
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- any individual > 20 weeks' gestation in triage or admitted at Children's Memorial Hermann Hospital (CMHH) and with blood pressure with >= 160/110 mmHg
Exclusion Criteria
- Active seizure, stroke, Congestive Heart Failure (CHF)/pulmonary edema, acute kidney injury (AKI), or myocardial infarction (MI) - A history of stroke, CHF, chronic kidney disease (CKD), MI - Have Hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome or thrombocytopenia (platelets < 100×10^9/L) - Persistent neurologic symptoms including headache >8/10 one hour after analgesic or blurry vision/loss of vision
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Case-Control
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Traditional clinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertension |
|
|
Updated clinical blood pressure threshold of SBP >= 180 mmHg for acute treatment of hypertension |
|
Recruiting Locations
UT Houston
Houston, Texas 77004
Houston, Texas 77004
More Details
- Status
- Recruiting
- Sponsor
- The University of Texas Health Science Center, Houston